News

N-able Insider Trading Activity: What You Need to Know

N-able Insider Trading Activity: What You Need to Know

N-able Insider Trading Activity: What You Need to Know

Ann Johnson, a Board Member at N-able (NABL), recently made waves with a noteworthy insider sell, as indicated in an SEC filing. This action drew attention to the timing and implications for prospective investors.

Details of the Insider Sale

On a recent filing, Johnson reported the sale of 34,568 shares of N-able, totaling approximately $266,173. The transaction's specifics are intriguing as investors dissect whether this signals confidence or concern regarding the company's future performance.

Current Stock Performance

N-able's shares are trading at $7.54, reflecting a slight increase of 0.13% in recent trading sessions. Monitoring these fluctuations can provide insights into market sentiment surrounding the company.

Understanding N-able's Business Model

N-able specializes in delivering cloud-based software solutions tailored for managed service providers (MSPs). Their innovative platform supports small and medium-sized enterprises in navigating digital transformation and enhancing operational efficiency.

Key Offerings and Market Strategy

With a robust suite of management, security, automation, and data protection solutions, N-able aims to simplify technology management for MSPs. The majority of N-able's revenue is generated from the United States, with notable presences in the United Kingdom and beyond, making it a globally competitive player.

Financial Insights: Recent Performance and Metrics

N-able reported a revenue growth rate of 9.88% for the quarter ending June 30, signifying a strong upward trajectory. This growth outpaces several competitors in the Information Technology sector, emphasizing N-able's successful business strategies.

Profitability Analysis

  • Gross Margin: The company boasts an impressive gross margin of 78.14%, showcasing effective cost management.
  • Earnings per Share (EPS): Currently, N-able's EPS stands at -0.02, slightly below the industry average.

Debt and Valuation Metrics

N-able maintains a favorable debt-to-equity ratio of 0.46, indicating a prudent approach to financing and capital structure that could attract investors looking for stability.

Valuation Comparisons

  • Price to Earnings (P/E) Ratio: The P/E ratio is reported at 753.0, reflecting the stock's premium valuation.
  • Price to Sales (P/S) Ratio: N-able's P/S ratio of 2.95 suggests potential undervaluation.
  • EV/EBITDA Analysis: The EV/EBITDA ratio of 19.13 indicates a disparity in market valuation sweetening the opportunity for strategic investors.

Importance of Insider Transactions

Understanding insider transactions can shed light on potential market movements. Generally, a purchase by an insider is interpreted positively, signaling confidence in the company’s prospects. However, sales can carry diverse interpretations depending on the context.

Formal Transaction Codes

Investors keen on the details will find distinction in transaction coding within SEC filings. A P denotes a purchase, while S signifies a sale, intertwined with other codes conveying different actions.

Frequently Asked Questions

What does Ann Johnson's sale of N-able shares mean for investors?

This sale could indicate personal financial planning rather than a loss of confidence in the company's stability.

How does N-able's recent revenue growth compare to its peers?

N-able’s revenue growth rate of 9.88% positions it above many competitors in the IT services sector.

What is the significance of N-able’s current stock price?

The current stock price of $7.54 reflects both market sentiment and future growth expectations for N-able.

How should investors interpret insider trading activities?

Investors should consider insider trades as one of many indicators when assessing market trends and company direction.

What are the implications of N-able's high P/E ratio?

A high P/E ratio often suggests strong growth expectations but may also indicate that the stock is priced for perfection.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Biopharma's YUPELRI® Receives Regulatory Green Light

Updated Category News Views 222

Theravance Biopharma's YUPELRI® Approves by China's NMPA Theravance Biopharma, Inc. (NASDAQ: TBPH) has announced a major achievement with the approval of YUPELRI® (revefenacin) by China’s National Medical Products Administration (NMPA). This landmark decision positions YUPELRI as the first once-daily nebulized long-acting muscarinic antagonist (LAMA) to be approved...

Continue Reading
Discover Passive Income Opportunities with SIX MINING's Innovative Platform

Updated Category News Views 233

Unleashing Passive Income Potential with SIX MINING SIX MINING is an innovative cryptocurrency investment platform established in the UK that is dedicated to creating an accessible environment for those interested in crypto mining. It aims to provide a green energy approach, allowing individuals from all backgrounds to benefit financially through easy-to-navigate...

Continue Reading
KARNO Linear Generator Gains Approval Under California RPS

Updated Category News Views 166

Hyliion Holdings Corp. (NYSE: HYLN) got its KARNO linear generator approved under California's Renewables Portfolio Standard (RPS), and that's no small feat. This move aligns perfectly with California's aggressive climate goals as it pushes for 60% of retail electricity sales to come from renewables by 2030, ramping up to full carbon neutrality by 2045. But let’s peel...

Continue Reading
nCino Reports Strong Preliminary Q1 Fiscal Year 2026 Results

Updated Category News Views 228

nCino Exceeds Revenue Expectations for First Quarter nCino, Inc. (NASDAQ: NCNO), a prominent provider of cutting-edge banking solutions, has proudly announced that its preliminary financial results for the recently concluded first quarter have surpassed the upper limits of the guidance it previously provided. These results encompass Total Revenues, Subscription Revenues,...

Continue Reading
Stantec's Strategic Role in Developing New Commercial Port

Updated Category News Views 123

Stantec's Role in the Development of a Modern Commercial Port Stantec is set to embark on an ambitious project to design and engineer a new commercial port of entry alongside design-build partners, Hensel Phelps and Jones Studio. This partnership has been awarded a significant contract worth $274.7 million, highlighting Stantec's expertise in transforming infrastructure...

Continue Reading